Series A funding round for New Amsterdam Pharma raising $190M in January 2021
Series A funding round for New Amsterdam Pharma raising $190M in January 2021
| Investor | Firm Type | Partner |
|---|
MorningsideLEAD | Private | — |
ForbionLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Non Profit | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Peter Thiel |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
New Amsterdam Pharma raised $190M in a Series A round.
The round was announced on 01/01/21.
The round was led by Ascendant BioCapital, Forbion, Jason Dinges.